Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

LXEO – lexeo therapeutics, inc. (US:NASDAQ)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LXEO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/20
05:05 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Feb 18 Filed by: Townsend Richard Nolan
Low Report
Form 4 Lexeo Therapeutics, Inc. For: Feb 18 Filed by: Townsend Richard Nolan
Report
2/20
05:05 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Feb 18 Filed by: Otero Jose Manuel
Low Report
Form 4 Lexeo Therapeutics, Inc. For: Feb 18 Filed by: Otero Jose Manuel
Report
2/20
05:05 pm
lxeo
Form 4/A Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Otero Jose Manuel
Low Report
Form 4/A Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Otero Jose Manuel
Report
2/18
04:26 pm
lxeo
Form 144 Lexeo Therapeutics, Inc. Filed by: Townsend Richard Nolan
Low Report
Form 144 Lexeo Therapeutics, Inc. Filed by: Townsend Richard Nolan
Report
2/18
03:51 pm
lxeo
Form 144 Lexeo Therapeutics, Inc. Filed by: Otero Jose Manuel
Low Report
Form 144 Lexeo Therapeutics, Inc. Filed by: Otero Jose Manuel
Report
2/18
03:34 pm
lxeo
Form 144 Lexeo Therapeutics, Inc. Filed by: See Tai Sandi
Low Report
Form 144 Lexeo Therapeutics, Inc. Filed by: See Tai Sandi
Report
2/18
03:28 pm
lxeo
Form 144 Lexeo Therapeutics, Inc. Filed by: Adler Eric
Low Report
Form 144 Lexeo Therapeutics, Inc. Filed by: Adler Eric
Report
2/18
03:28 pm
lxeo
Form 144 Lexeo Therapeutics, Inc. Filed by: Robertson Jenny
Low Report
Form 144 Lexeo Therapeutics, Inc. Filed by: Robertson Jenny
Report
2/17
04:55 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Feb 13 Filed by: Bhalla Narinder Pal
Low Report
Form 4 Lexeo Therapeutics, Inc. For: Feb 13 Filed by: Bhalla Narinder Pal
Report
2/17
04:39 pm
lxeo
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: CITADEL ADVISORS LLC
Low Report
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: CITADEL ADVISORS LLC
Report
2/17
04:03 pm
lxeo
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: Paradigm Biocapital Advisors LP
Low Report
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: Paradigm Biocapital Advisors LP
Report
2/17
06:40 am
lxeo
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Low Report
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Report
2/13
05:34 pm
lxeo
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
Low Report
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
Report
2/6
05:00 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Feb 04 Filed by: Townsend Richard Nolan
Low Report
Form 4 Lexeo Therapeutics, Inc. For: Feb 04 Filed by: Townsend Richard Nolan
Report
2/6
05:00 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Feb 04 Filed by: Tamayo Louis Edward
Low Report
Form 4 Lexeo Therapeutics, Inc. For: Feb 04 Filed by: Tamayo Louis Edward
Report
2/6
05:00 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Feb 04 Filed by: Otero Jose Manuel
Low Report
Form 4 Lexeo Therapeutics, Inc. For: Feb 04 Filed by: Otero Jose Manuel
Report
2/5
04:45 pm
lxeo
Form 3 Lexeo Therapeutics, Inc. For: Jan 20 Filed by: Bhalla Narinder Pal
Low Report
Form 3 Lexeo Therapeutics, Inc. For: Jan 20 Filed by: Bhalla Narinder Pal
Report
2/5
04:17 pm
lxeo
Form 8-K Lexeo Therapeutics, Inc. For: Jan 30
Medium Report
Form 8-K Lexeo Therapeutics, Inc. For: Jan 30
Report
1/30
02:19 pm
lxeo
Form SCHEDULE 13G Lexeo Therapeutics, Inc. Filed by: VANGUARD GROUP INC
Low Report
Form SCHEDULE 13G Lexeo Therapeutics, Inc. Filed by: VANGUARD GROUP INC
Report
1/29
07:59 pm
lxeo
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: Affinity Asset Advisors, LLC
Low Report
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: Affinity Asset Advisors, LLC
Report
1/27
07:32 am
lxeo
Form 8-K Lexeo Therapeutics, Inc. For: Jan 27
Low Report
Form 8-K Lexeo Therapeutics, Inc. For: Jan 27
Report
1/21
12:32 pm
lxeo
Form SCHEDULE 13G Lexeo Therapeutics, Inc. Filed by: BlackRock, Inc.
Low Report
Form SCHEDULE 13G Lexeo Therapeutics, Inc. Filed by: BlackRock, Inc.
Report
1/12
11:46 am
lxeo
Form 8-K Lexeo Therapeutics, Inc. For: Jan 12
Medium Report
Form 8-K Lexeo Therapeutics, Inc. For: Jan 12
Report
12/8
11:45 am
lxeo
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC
Low Report
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC
Report
11/28
06:04 am
lxeo
Form EFFECT Lexeo Therapeutics, Inc.
Low Report
Form EFFECT Lexeo Therapeutics, Inc.
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2026, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0